Search research articles
Contact Us
Filters
Showing results (131-140 of 224) with videos related to
Page
of 23
Sort By:
Neuroscience
|
September 29, 1999
Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions
A Gobert, J M Rivet, L Cistarelli, et al.
Journal of Neurochemistry
|
May 1, 1996
Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo
A Gobert, F Lejeune, J M Rivet, et al.
European Journal of Pharmacology
|
August 24, 1993
WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo
F Lejeune, J M Rivet, A Gobert, et al.
Brain Research
|
June 17, 1982
The influence of selective adeno- and neurointermedio-hypophysectomy upon plasma and brain levels of beta-endorphin and their response to stress in rats
R Przewłocki, M J Millan, C Gramsch, et al.
European Journal of Pharmacology
|
May 30, 1997
Binding profile of the novel 5-HT1B/1D receptor antagonist, [3H]GR 125,743, in guinea-pig brain: a comparison with [3H]5-carboxamidotryptamine
V Audinot, S Lochon, A Newman-Tancredi, et al.
British Journal of Pharmacology
|
March 1, 1997
Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635
A Newman-Tancredi, C Conte, C Chaput, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1997
[35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents
A Newman-Tancredi, V Audinot, C Chaput, et al.
Neuropharmacology
|
April 1, 1997
Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry
A Newman-Tancredi, C Conte, C Chaput, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 5, 1999
Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo
M J Millan, A Gobert, V Audinot, et al.
Molecular Pharmacology
|
October 20, 2000
Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry
A Newman-Tancredi, V Audinot, C Moreira, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 224) with videos related to
Sort By:
Page
of 23
Neuroscience
|
September 29, 1999
Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions
A Gobert, J M Rivet, L Cistarelli, et al.
Journal of Neurochemistry
|
May 1, 1996
Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo
A Gobert, F Lejeune, J M Rivet, et al.
European Journal of Pharmacology
|
August 24, 1993
WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo
F Lejeune, J M Rivet, A Gobert, et al.
Brain Research
|
June 17, 1982
The influence of selective adeno- and neurointermedio-hypophysectomy upon plasma and brain levels of beta-endorphin and their response to stress in rats
R Przewłocki, M J Millan, C Gramsch, et al.
European Journal of Pharmacology
|
May 30, 1997
Binding profile of the novel 5-HT1B/1D receptor antagonist, [3H]GR 125,743, in guinea-pig brain: a comparison with [3H]5-carboxamidotryptamine
V Audinot, S Lochon, A Newman-Tancredi, et al.
British Journal of Pharmacology
|
March 1, 1997
Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635
A Newman-Tancredi, C Conte, C Chaput, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1997
[35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents
A Newman-Tancredi, V Audinot, C Chaput, et al.
Neuropharmacology
|
April 1, 1997
Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry
A Newman-Tancredi, C Conte, C Chaput, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 5, 1999
Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo
M J Millan, A Gobert, V Audinot, et al.
Molecular Pharmacology
|
October 20, 2000
Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry
A Newman-Tancredi, V Audinot, C Moreira, et al.
Page
of 23